1460882960-f3cdb5fe-a706-45e1-bac6-2adddbfe7217

1. A method for forming a radiation flood source, the method comprising:
preparing a radioactive isotope carrier solution;
loading the radioactive isotope carrier solution into a radioactive isotope carrier solution cartridge;
loading a separate border cartridge into a plotter;
selecting and configuring a shape of an active area;
setting a border to be placed around the active area;
printing the active area by utilizing the radioactive isotope carrier solution cartridge on a sheet substrate; and
printing the border by utilizing the separate border cartridge on the sheet substrate.
2. The method of claim 1, further comprising:
laminating the printed sheet substrate to block radioactive isotopes on the active area from separating from the active area; and
placing the laminated printed sheet substrate in a protective housing.
3. The method of claim 1, further comprising:
cutting an active sheet around the printed border from the printed sheet substrate;
laminating the active sheet to block radioactive isotopes on the active area from separating from the active area; and
placing the laminated active sheet in a protective housing.
4. The method of claim 1, further comprising:
cutting an active sheet around the printed border from the printed sheet substrate;
laminating the active sheet to block radioactive isotopes on the active area from separating from the active area;
testing the laminated active sheet to verify an integrity of the active area; and
placing the tested active sheet in a protective housing.
5. The method of claim 1, wherein the preparing of the radioactive isotope carrier solution comprises:
drying a radioactive isotope solution to form dried radioactive isotopes; and
mixing the dried radioactive isotopes with a pigmentless carrier solution to prepare the radioactive isotope carrier solution.
6. The method of claim 1, wherein the active area is printed only by the radioactive isotope carrier cartridge, and the border is printed only by the border cartridge.
7. The method of claim 1, wherein the radioactive isotope carrier solution comprises an active material composed of radioactive isotopes selected from the group consisting of Cobalt 57, Iodine 125, Palladium 103, Barium 133, Carbon 14, Gadolinium 153, Phosphorus 33, Tellurium 99, and combinations thereof.
8. The method of claim 7, wherein the radioactive isotope carrier solution is formulated with a pigmentless carrier solution comprising cobalt chloride, ethylene glycol, glycerin, and hydrochloric acid and to have a viscosity adapted for being inkjet printed on the sheet substrate.
9. The method of claim 8, wherein the pigmentless carrier solution is composed of a mixture of 600 mg of cobalt chloride, 10 ml ethylene glycol, 10 ml glycerin, and 80 ml of 0.1M hydrochloric acid.
10. The method of claim 1, wherein:
the radioactive isotope carrier solution is a pigmentless radioactive isotope carrier solution;
the printing of the active area comprises printing the active area by utilizing only the pigmentless radioactive isotope carrier solution;
the separate border cartridge comprises a pigmented ink solution; and
the printing of the border comprises printing the border around the area by utilizing only the pigmented ink solution.
11. A plotting system for forming a radiation flood source comprising:
a sheet substrate supply configured to provide a sheet substrate;
a radioactive isotope carrier solution cartridge containing a radioactive isotope carrier solution and configured to print an active area onto the sheet substrate;
a separate border cartridge configured to print a border around the active area on the sheet substrate; and
a controller configured to control the radioactive isotope carrier solution cartridge to print the active area onto the sheet substrate and the separate border cartridge to print the border around the active area on the sheet substrate.
12. The plotting system of claim 11, wherein the radioactive isotope carrier solution cartridge is an inkjet cartridge.
13. The plotting system of claim 11, wherein the radioactive isotope carrier solution is a mixture of dried radioactive isotopes and a pigmentless carrier solution.
14. The plotting system of claim 11, wherein the active area is printed only by the radioactive isotope carrier cartridge, and the border is printed only by the border cartridge.
15. The plotting system of claim 11, wherein the radioactive isotope carrier solution comprises an active material composed of radioactive isotopes selected from the group consisting of Cobalt 57, Iodine 125, Palladium 103, Barium 133, Carbon 14, Gadolinium 153, Phosphorus 33, Tellurium 99, and combinations thereof.
16. The plotting system of claim 11, wherein the radioactive isotope carrier solution is formulated with a pigmentless carrier solution comprising cobalt chloride, ethylene glycol, glycerin, and hydrochloric acid and to have a viscosity adapted for being inkjet printed on the sheet substrate.
17. The plotting system of claim 16, wherein the pigmentless carrier solution is composed of a mixture of 600 mg of cobalt chloride, 10 ml ethylene glycol, 10 ml glycerin, and 80 ml of 0.1M hydrochloric acid.
18. The plotting system of claim 11, wherein the separate border cartridge contains a pigmented solution composed of color pigments selected from the group consisting of black pigments, cyan pigments, yellow pigments, magenta pigments, and combinations thereof.
19. A radiation flood source comprising:
a paper sheet;
a pigmentless radioactive fill printed on the paper sheet and comprising radioactive isotopes selected from the group consisting of Cobalt 57, Iodine 125, Palladium 103, Barium 133, Carbon 14, Gadolinium 153, Phosphorus 33, Tellurium 99, and combinations thereof; and
a pigmented border printed on the paper sheet and around the pigmentless radioactive fill.
20. The radiation flood source of claim 19, further comprising:
a first protective sheet laminated with the paper sheet with the radioactive isotopes therebetween.
21. The radiation flood source of claim 20, further comprising a second protective sheet and the paper sheet being laminated between the first protective sheet and the second protective sheet.
22. The radiation flood source of claim 21, further comprising a housing having an interior space housing the paper sheet with the pigmentless radioactive fill.
23. The radiation flood source of claim 22, further comprising a spacer also housed in the interior space of the housing and between an interior side of the housing facing the paper sheet and the paper sheet.
24. The radiation flood source of claim 19, further comprising a housing having an interior space housing the paper sheet with the pigmentless radioactive fill.
25. The radiation flood source of claim 24, further comprising a spacer also housed in the interior space of the housing and between an interior side of the housing facing the paper sheet and the paper sheet.
26. The radiation flood source of claim 19, wherein the pigmentless radioactive fill further comprises a pigmentless carrier material.
27. The radiation flood source of claim 19, wherein the pigmented border comprises color pigments selected from the group consisting of black pigments, cyan pigments, yellow pigments, magenta pigments, and combinations thereof.
28. The radiation flood source of claim 19, wherein the pigmentless radioactive fill is transparent to visible light.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. An in vivo method for monitoring the concentration of blood glucose, the method comprising:
applying at least one small molecule metabolic reporter (SMMR) to at least one surface of skin for a predetermined period of time;
causing penetration of the at least one SMMR to a location having a depth corresponding to the stratum germinativum;
controlling a temperature at said location, wherein said controller increases blood flow to the dermal layer below said location;
monitoring a change in the stratum germinativum intracellular concentration of glucose in a metabolic pathway by detecting changes in the at least one SMMR at one or more time points using an optical reader; and
correlating the change in the stratum germinativum intracellular glucose concentration with in vivo blood glucose levels.
2. The method of claim 1, wherein the at least one SMMR comprises a mitochondrial stain sensitive to membrane potential or chemical gradient.
3. The method of claim 2, wherein the mitochondrial stain is a polycyclic aromatic hydrocarbon dye selected from the group consisting of: rhodamine 123; di-4-ANEPPS; di-8-ANEPPS; DiBAC4(3); RH421; tetramethylrhodamine ethyl ester, perchlorate; tetramethylrhodamine methyl ester, perchlorate; 2-(4-(dimethylamino)styryl)-N-ethylpyridinium iodide; 3,3\u2032-dihexyloxacarbocyanine; 5,5\u2032,6,6\u2032-tetrachloro-1,1\u2032,3,3\u2032-tetraethyl-benzimidazolylcarbocyanine chloride; 5,5\u2032,6,6\u2032-tetrachloro-1,1\u2032,3,3\u2032-tetraethyl-benzimidazolylcarbocyanine iodide; nonylacridine orange; dihydrorhodamine 123; dihydrorhodamine 123, dihydrochloride salt; xanthene; 2\u2032,7\u2032-bis-(2-carboxyethyl)-5-(and -6)-carboxyfluorescein; benzenedicarboxylic acid, 2(or 4)-10-(dimethylamino)-3-oxo-3-H-benzocxanthene-7-yl; and iodine dissolved in potassium iodide.
4. The method of claim 1, wherein the at least one SMMR comprises a dye or stain that transfers energy from a molecule generated as a result of an oxidative metabolic pathway and that has a stoichiometric or substantially stoichiometric relationship with glucose concentration.
5. The method of claim 1, wherein the at least one SMMR comprises a dye selected from the group consisting of: coumarin; anthraquinones; cyanine dyes; azo dyes; xanthene dyes; arylmethine dyes; and ruthenium bipyridyl complexes.
6. The method of claim 1, wherein the at least one SMMR comprises a protein labeled fluorophore.
7. The method of claim 6, wherein the protein labeled fluorophore is Glucose Oxidase-Labeled Fluorophore (GO-LF) or Glucose Oxidase-Intercalated Fluorophore (GO-IF).
8. The method of claim 1, wherein the at least one SMMR comprises a protein comprising a photooxidizable cofactor.
9. The method of claim 8, wherein the protein comprising a photooxidizable cofactor is Glucose Oxidase (GOx) with a flavin adenine dinucleotide (FAD) in the triplet state (GOx-3FAD*).
10. The method of claim 1, wherein monitoring the change in the stratum germinativum intracellular glucose concentration comprises detecting radiation at least one wavelength above 350 nm.
11. The method of claim 1, wherein the at least one SMMR is formulated as a cream, emulsion, ointment, oil, disposable gel film patch, reservoir device or paint.
12. The method of claim 1, wherein the at least one SMMR penetrates within the skin using at least one technique selected from the group consisting of: electroporation, solvent transport, tattooing, injecting, microneedle delivery, and passive transport.
13. The method of claim 1, wherein the monitoring comprises quantification of the change in fluorescence or absorption using fluorescence or absorption spectroscopy.
14. The method of claim 1, wherein the at least one SMMR penetrates within the skin using microneedle delivery.
15. An in vivo method for measuring blood glucose levels, said in vivo method comprising controlling a temperature at a population of stratum germinativum cells to increase blood flow to a dermal layer below said stratum germinativum cells, and monitoring intracellular glucose concentration in the population of stratum germinativum cells, wherein the monitoring comprises measuring the fluorescence spectrum emitted by at least one small molecule metabolic reporter (SMMR), wherein at least one fluorescence spectrum emitted by the at least one SMMR is stoichiometrically related to the glucose intracellular concentration in the population of stratum germinativum cells, whereby analyzing the relatedness provides the in vivo blood glucose level.
16. The method of claim 15, wherein the population of stratum germinativum cells has a predominantly glycolytic metabolism or can be induced to have a glycolytic metabolism.
17. The method of claim 16, wherein the population of stratum germinativum cells is located in the epidermis, wherein the epidermis comprises a dynamic, metabolically homogeneous, and homeostatic population of cells.
18. The method of claim 16, wherein the population of stratum germinativum cells having a glycolytic metabolism comprise live keratinocytes.
19. The method of claim 15, wherein the intracellular glucose concentration is monitored in the population of stratum germinativum cells via measurement of one or more specific metabolite or analyte of the glycolytic pathway that has a stoichiometric or substantially stoichiometric relationship with glucose concentration.
20. The method of claim 15, wherein the monitoring of intracellular glucose concentration in the population of stratum germinativum cells, comprises measuring a physico-chemical parameter that is related to the glycolytic pathway, wherein said physic-chemical parameter comprises a stoichiometric or substantially stoichiometric relationship with glucose concentration.
21. The method of claim 15, wherein the population of stratum germinativum cells comprises a predominantly oxidative metabolism or can be induced to comprise a metabolism predominantly based on oxidative phosphorylation.
22. The method of claim 21, wherein the monitoring of intracellular glucose concentration in the population of stratum germinativum cells, comprises measuring a metabolite or analyte that is generated as a result of an oxidative metabolic pathway, wherein said metabolite or analyte comprises a stoichiometric or substantially stoichiometric relationship with glucose concentration.
23. The method of claim 21, wherein the monitoring of intracellular glucose concentration in the population of stratum germinativum cells, comprises measuring a physico-chemical parameter that is generated as a result of an oxidative metabolic pathway and that comprises a stoichiometric or substantially stoichiometric relationship with glucose concentration.
24. A noninvasive method for monitoring in vivo blood glucose levels, the method comprising:
applying at least one small molecule metabolic reporter (SMMR) to at least one surface of skin for a predetermined period of time;
causing penetration of the at least one SMMR to a location corresponding to the stratum germinativum;
contacting the at least one SMMR with one or more metabolites or analytes indicative of stratum germinativum intracellular glucose concentration;
controlling a temperature at said location, wherein said controlling increases blood flow to the dermal layer below said location;
monitoring a change in the stratum germinativum intracellular glucose concentration by detecting changes in the at least one SMMR using an optical reader, and
correlating the change in the stratum germinativum intracellular glucose concentration with in vivo blood glucose levels.
25. The method of claim 24, wherein the at least one small molecule metabolic reporter is selected from the group consisting of a fluorophore, a protein labeled fluorophore, a protein comprising a photooxidizable cofactor, a protein comprising an intercalated fluorophore, a mitochondrial vital stain or dye, a dye exhibiting one or more of a redox potential, a membrane localizing dye, a dye comprising energy transfer properties, a pH indicating dye, a coumarin dye, an anthraquinone dye, a cyanine dye, an azo dye, a xanthene dye, an arylmethine dye, and a ruthenium bipyridyl complex dye.
26. The method of claim 25, wherein the protein labeled fluorophore is Glucose Oxidase-Labeled Fluorophore (GO-LF) and the one or more metabolites is glucose.
27. The method of claim 25, wherein the protein comprising a photooxidizable cofactor is Glucose Oxidase (GOx) with a flavin adenine dinucleotide (FAD) in the triplet state (GOx 3FAD*).
28. The method of claim 25, wherein the mitochondrial vital stain or dye is a polycyclic aromatic hydrocarbon dye selected from the group consisting of: Rhodamine 123; Di-4-ANEPPS; Di-8-ANEPPS; DiBAC4(3); RH421; Tetramethylrhodamine ethyl ester, perchlorate; Tetramethylrhodamine methyl ester, perchlorate; 2-(4-(dimethylamino)styryl)-N-ethylpyridinium iodide; 3,3\u2032-Dihexyloxacarbocyanine; 5,5\u2032,6,6\u2032-tetrachloro-1,1\u2032,3,3\u2032-tetraethyl-benzimidazolylcarbocyanine chloride; 5,5\u2032,6,6\u2032-tetrachloro-1,1\u2032,3,3\u2032-tetraethyl-benzimidazolylcarbocyanine iodide; Nonylacridine Orange; Dihydrorhodamine 123; Dihydrorhodamine 123, dihydrochloride salt; xanthene; 2\u2032,7\u2032-bis-(2-carboxyethyl)-5-(and -6)-carboxyfluorescein; benzenedicarboxylic acid, 2(or 4)-10-(dimethylamino)-3-oxo-3-H-benzocxanthene-7-yl; and iodine dissolved in potassium iodide.
29. The method of claim 25, where monitoring the change in stratum germinativum intracellular glucose concentration comprises measuring at least one spectral emission at a wavelength above 450 nm.
30. The method of claim 24, wherein the one or more metabolites or analytes are selected from the group consisting of glucose, lactate, H+, Ca2+, Mg2+, Na+, K+, ATP, ADP, Pi, glycogen, pyruvate, NAD(P)+, NAD(P)H, FAD, FADH2, and O2.
31. A method for determining in vivo blood glucose concentration, comprising the steps of:
performing an instrument response measurement on a calibration target and recording the response data;
applying a mixture comprising at least one SMMR to the skin in a first controlled area such that the at least one SMMR resides in the stratum germinativum layer of the skin;
applying a second mixture comprising at least one SMMR to the skin in a second controlled area;
perturbing the second controlled area such that one or more extreme changes at the second controlled area are achieved;
performing a calibration measurement on the perturbed area and recording the calibration data;
performing a background measurement on an area of skin that has no SMMR and recording this background data;
controlling a temperature at the first controlled area, wherein said controlling increases blood flow to a dermal layer below the first controlled area;
illuminating the first controlled area with light and performing a first measurement on the first controlled area;
detecting at least one wavelength spectrum of light reflected back from the first controlled area;
performing at least a second measurement on the first controlled area at wavelengths suitable for each SMMR present;
calculating at least one parameter from the response data to normalize the background data, calibration data and measurement data for the response using a spectrometer;
calculating at least one parameter from the background data to correct the calibration data and measurement data for emission, absorption and scattering properties of the tissue; and
calculating at least one stratum germinativum intracellular glucose parameter from the calibration data to relate the measurement data to the blood glucose concentration;
thereby determining in vivo blood glucose concentration.
32. The method of claim 31, wherein the one or more extreme changes is a change in concentration of a metabolite or analyte between a zero or near zero concentration and a saturation level or near saturation level concentration.
33. The method of claim 31, wherein the mixture comprising at least one SMMR penetrates within the stratum germinativum layer of skin using microneedle delivery.